High-Throughput In Vivo Screening Using Barcoded mRNA Identifies Lipid Nanoparticles With Extrahepatic Tropism for In Situ Immunoengineering
Adv Mater. 2026 Jan 28:e14370. doi: 10.1002/adma.202514370. Online ahead of print.ABSTRACTInterest continues to grow in the use of mRNA vaccines and therapeutics. While effective for immunization against infectious diseases, lipid nanoparticle (LNP) formulations used for other mRNA delivery applicat

